Treatment

MTX-463 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
This study, called WISPer, is testing a new medicine called MTX-463 for Idiopathic Pulmonary Fibrosis (IPF). It's comparing MTX-463 to a dummy medicine (placebo) to see if it's safe and effective for people with this lung condition.
For: Idiopathic Pulmonary Fibrosis
United States · Argentina · Australia